Insights & Perspectives

Filter by

Therapeutic Area / Research

Year Starting

Year Ending

Search Insights:
Showing 1 to 10 of 349
Filter by: Unfiltered

Datasheet | Nov 20, 2014

Biosimilars in China: Market Access and Barriers

This report provides insights into the opportunities and barriers in the Chinese biosimilars market, how to maximise these opportunities and reduce the threats to reap return-on-investment.

Read more | Share

White Paper | Nov 19, 2014

Key Findings from the 2014 European Society of Medical Oncology (ESMO) Annual Meeting

This issue of Oncology Conference Insight highlights significant information presented at ESMO 2014, which took place September 26-30 in Madrid, Spain. Our goal is to provide our clients with the latest information presented at oncology meetings.

Read more | Share

Infographic | Nov 10, 2014

Protecting our future - Changing habits to guard against diabetes

382 million people are living with diabetes worldwide. By 2035, 592 million people or one person in 10 will have the disease. 316 million people are currently at high risk of developing type 2 diabetes, and that is expected to increase to almost 500 million within a generation.

White Paper | Nov 7, 2014

Cancer Treatment Dynamics

Kantar Health explores what factors effect cancer treatment. We go on to discuss how value will be defined in the future for oncology. Lastly, we identify how manufacturers can develop a strong product value proposition.

Read more | Share

Infographic | Nov 4, 2014

Smoking in the United States

19% of adults in the U.S. smoked cigarettes in 2013 vs. 24% in 1998. 48% of American adults said they have smoked at some point in their lives. Of those who have ever smoked, 58% have quit and 14% are trying to quit.

Case Study | Oct 30, 2014

Quantifying granular patient segments to inform commercial decisions

A mid-sized, multinational pharmaceutical company, needed to quantify subsegments of a targeted patient population, assess the competitive landscape, and forecast the revenue potential for an early-stage asset. The insights they gained through their partnership with Kantar Health enabled them to validate market characteristics and adjust their commercial strategy to address subsegments of the market and capitalize on the barriers to adherence based on pain severity.

Read more | Share

White Paper | Oct 29, 2014

The Battle Between Big Data and Big Privacy

As one of the most mentioned buzzwords in the market research industry, it is impossible to avoid the term “Big Data.” Big Data is promised to yield big savings and is transforming healthcare; it is certainly the future with its big benefits. However, Big Data comes with a big question – privacy, which is particularly important in healthcare. The “Big Privacy” movement already has advocates and is leading to increasingly bigger fines. Will Big Privacy kill Big Data?

Read more | Share

Infographic | Oct 27, 2014

Women and Stroke - Knowing the Risks and Taking Preventive Steps

Stroke is largely preventable through lifestyle management, yet to beat stroke, women need sex-specific information on their risks and preventive practices.

White Paper | Oct 21, 2014

Pharma Industry Addresses Unmet Needs in Pain

Kantar Health explores some of the challenges affecting the pain market today, including abuse potential, recent regulatory changes, and how the gap between prevalence and treatment leads to large unmet needs.

Read more | Share

Infographic | Oct 7, 2014

Regular exercise can delay or decrease the effects of arthritis

Making healthy lifestyle choices such as exercising can help delay or decrease the effects of arthritis. Live better and age well.

Page  < 123456789 >